Vimta Labs Limited
Diagnostics & Research · Healthcare
2 appearances
Latest appearance 2026-05-06
Vimta Labs Limited
Equibles does not estimate personal net worth.
Sathya Senevas Neerukonda has spoken on 2 earnings calls across 1 company, most recently for Vimta Labs Limited on May 6, 2026. Vimta Labs Limited is classified in the Diagnostics & Research industry within the Healthcare sector.
“Other general product release, which is already what you call approved in the market, and if they are filing ANDAs, then to support their ANDA 5.6. It includes both approved products, ANDA, new products, 505B2s, NDAs.”
“At what stage are we on-boarding the projects? Biologics, we do multiple services for any biologics, biosimilars and peptides. One is analytical services, one is characterization, one is on the clinical side, we do pre-clinical studies, and the new one which we are starting now is the formation development service.”
Vimta Labs Limited
Transcript header (unverified)
Vimta Labs Limited
Diagnostics & Research · Healthcare
“Vimta Labs Limited Q4 FY '26 Earnings Conference Call”
Vimta Labs Limited
Transcript of the Q3-2026 Earnings Investor call- 28.01.2026
Vimta Labs Limited